Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc logo
RCKT

Rocket Pharmaceuticals Inc (RCKT)

$18.884.42%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$17.54
Day's Range
$19.0
$7.57
52-Week Range
$25.62
1 month return3.11%
3 month return17.86%
1 year return25.99%
5 year return95.67%

Company Information

Rocket Pharmaceuticals, Inc. is advancing an integrated and sustainable pipeline of genetic therapies that correct the root cause of complex and rare childhood disorders. The Company's platform-agnostic approach enables it to design the best therapy for each indication, creating potentially transformative options for patients afflicted with rare genetic diseases. Rocket's clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, Pyruvate Kinase Deficiency (PKD) a rare, monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia, and Infantile Malignant Osteopetrosis (IMO), a bone marrow-derived disorder. Rocket's first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon disease, a devastating, pediatric heart failure condition.
OrganizationRocket Pharmaceuticals Inc
Employees151
CEODr. Gaurav D. Shah M.D.
IndustryHealth Technology

Analyst Recommendation

based on 12 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 12 Wall street analysts offering stock ratings for Rocket Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 178.71%

Current

$18.88

Target

$52.62

Recommendation Trend

Based on 12 analyst

Current1M Ago3M Ago
Buy
12
18
18
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
1.3B
Book Value
$5.41
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.69
Wall Street Target Price
52.62

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
3.83
Enterprise Value
1.1B
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
-5.93

Technicals

Beta
1.27
50 Day MA
16.74
200 Day MA
15.03

Institutional Holdings

RTW INVESTMENTS, LLC

20.88%

Wellington Management Company LLP

4.6%

Vanguard Group Inc

4.52%

State Street Corporation

4.48%

Westfield Capital Management Company, LP

3.51%

Maverick Capital Ltd

3.35%

Discover more

Frequently Asked Questions

What is Rocket Pharmaceuticals Inc share price today?

Can Indians buy Rocket Pharmaceuticals Inc shares?

How can I buy Rocket Pharmaceuticals Inc shares from India?

Can Fractional shares of Rocket Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Rocket Pharmaceuticals Inc stocks?

What are today’s High and Low prices of Rocket Pharmaceuticals Inc?

What are today’s traded volumes of Rocket Pharmaceuticals Inc?

What is today’s market capitalisation of Rocket Pharmaceuticals Inc?

What is the 52 Week High and Low Range of Rocket Pharmaceuticals Inc?

How much percentage Rocket Pharmaceuticals Inc is down from its 52 Week High?

How much percentage Rocket Pharmaceuticals Inc is up from its 52 Week low?

What are the historical returns of Rocket Pharmaceuticals Inc?

Who is the Chief Executive Officer (CEO) of Rocket Pharmaceuticals Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*